Roles of the Jejunum and Ileum in the First-Pass Effect as Absorptive Barriers for Orally Administered Tacrolimus
- 30 April 2002
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 103 (2) , 215-222
- https://doi.org/10.1006/jsre.2002.6359
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 14 references indexed in Scilit:
- Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living‐donor liver transplantationClinical Pharmacology & Therapeutics, 2001
- Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipientClinical Pharmacology & Therapeutics, 2000
- Hepatic Extraction of Tacrolimus in Rats with Experimental Liver Diseases.Biological & Pharmaceutical Bulletin, 1998
- The barrier function of CYP3A4 and P-glycoprotein in the small bowelAdvanced Drug Delivery Reviews, 1997
- Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*Clinical Pharmacology & Therapeutics, 1997
- Segmental Small Bowel Transplantation in the Rat: Comparison of Lipid Absorption Between Jejunal and Ileal GraftsJournal of Parenteral and Enteral Nutrition, 1996
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.Journal of Clinical Investigation, 1992
- Heterogeneity of cytochrome P450IIIA expression in rat gut epitheliaGastroenterology, 1992
- Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.Journal of Clinical Investigation, 1987